-
1دورية أكاديمية
المصدر: Journal of Cardiovascular and Thoracic Research, Vol 14, Iss 3, Pp 201-204 (2022)
مصطلحات موضوعية: glycoprotein iib/iiia inhibitors, alveolar hemorrhage, percutaneous coronary intervention, acute coronary syndromes, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-14-201.pdfTest; https://doaj.org/toc/2008-5117Test; https://doaj.org/toc/2008-6830Test
-
2دورية أكاديمية
المؤلفون: Gašper Tonin, Jasna Klen
المصدر: International Journal of Molecular Sciences; Volume 24; Issue 6; Pages: 5446
مصطلحات موضوعية: therapeutic peptides, glycoprotein IIb/IIIa inhibitors, antiplatelet drug, acute coronary syndrome, percutaneous coronary intervention, ischemic stroke, cardiogenic shock, carotid stenting, intracranial aneurysm stenting, septic shock
جغرافية الموضوع: agris
وصف الملف: application/pdf
العلاقة: Biochemistry; https://dx.doi.org/10.3390/ijms24065446Test
-
3دورية أكاديمية
المؤلفون: I. S. Bessonov, A. A. Shadrin, S. S. Sapozhnikov, V. V. Ryabov, S. V. Popov, И. С. Бессонов, А. А. Шадрин, С. С. Сапожников, В. В. Рябов, С. В. Попов
المساهمون: The work was carried out within the framework of the state assignment of the Ministry of Science and Higher Education of the Russian Federation (topic no АААА-А20-120060890012-5)., Работа выполнена в рамках государственного задания Министерства науки и высшего образования Российской Федерации (тема № АААА-А20-120060890012-5).
المصدر: The Siberian Journal of Clinical and Experimental Medicine; Том 38, № 2 (2023); 122-131 ; Сибирский журнал клинической и экспериментальной медицины; Том 38, № 2 (2023); 122-131 ; 2713-265X ; 2713-2927
مصطلحات موضوعية: феномен «no-reflow», percutaneous coronary intervention, glycoprotein IIb/IIIa inhibitors, no-reflow phenomenon, чрескожное коронарное вмешательство, ингибиторы гликопротеина IIbIIIa рецепторов тромбоцитов, феномен микроваскулярной обструкции
وصف الملف: application/pdf
العلاقة: https://www.sibjcem.ru/jour/article/view/1796/820Test; Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019;40(2):87–165. DOI:10.1093/eurheartj/ehy394.; Клинические рекомендации Минздрава РФ, Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы; 2020. DOI:10.15829/29/1560-4071-2020-4103.; Annibali G., Scrocca I., Aranzulla T.C., Meliga E., Maiellaro F., Musumeci G. “No-reflow” phenomenon: A contemporary review. J. Clin. Med. 2022;11(8):2233. DOI:10.3390/jcm11082233.; Kloner R.A., King K.S., Harrington M. No-reflow phenomenon in heart and brain. Am. J. Physiol. Heart Circ. Physiol. 2018;315(3):550–562. DOI:10.1152/ajpheart.00183.2018.; Сухинина Т.С., Певзнер Д.В., Мазуров А.В., Власик Т.Н., Соловьева Н.Г., Кострица Н.С. и др. Роль блокаторов гликопротеина IIb/IIIa рецепторов тромбоцитов при современном лечении больных с острым коронарным синдромом. Кардиология. 2022;62(4):64–72. DOI:10.18087/cardio.2022.4.n2020.; Petronio A.S., De Carlo M., Ciabatti N., Amoroso G., Limbruno U., Palagi C. et al. Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine. Am. Heart J. 2005;150(5):1015. DOI:10.1016/j.ahj.2005.07.012.; Stone G.W., Maehara A., Witzenbichler B., Godlewski J., Parise H., Dambrink J.H. et al. INFUSE-AMI Investigators. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012;307(17):1817–1826. DOI:10.1001/jama.2012.421.; Morales-Ponce F.J., Lozano-Cid F.J., Martinez-Romero P., Gonzalez-Perez P., Sanchez-Brotons J.A., Diaz-Torres I. et al. Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction. EuroIntervention. 2019;14(16):1668–1675. DOI:10.4244/EIJ-D-18-00885.; Бессонов И.С., Кузнецов В.А., Горбатенко Е.А., Сапожников С.С., Дьякова А.О., Зырянов И.П. и др. Шкала оценки риска феномена no-reflow при чрескожных коронарных вмешательствах у пациентов с острым инфарктом миокарда с подъемом сегмента ST. Патология кровообращения и кардиохирургия. 2020;24(3):68. DOI:10.21688/1681-3472-2020-3S-68-76.; Бессонов И.С., Дьячков С.М. Калькулятор расчета риска возникновения феномена “no-reflow”. Свидетельство о регистрации программы для ЭВМ 2020661255, 21.09.2020.; Gibson C.M., de Lemos J.A., Murphy S.A., Marble S.J., McCabe C.H., Cannon C.P. et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21):2550–2554. DOI:10.1161/01.cir.103.21.2550.; Antman E.M., Cohen M., Bernink P.J., McCabe C.H., Horacek T., Papuchis G. et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–842. DOI:10.1001/jama.284.7.835.; Van’t Hof A.W.J., Liem A., Suryapranata H., Hoorntje J.C.A., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998;97(23):2302–2306. DOI:10.1161/01.cir.97.23.2302.; Вышлов Е.В., Алексеева Я.В., Усов В.Ю., Мочула О.В., Рябов В.В. Синдром микрососудистого повреждения миокарда у пациентов с первичным инфарктом миокарда с подъемом сегмента ST: распространенность и связь с клиническими характеристиками. Сибирский журнал клинической и экспериментальной медицины. 2022;37(1):36–46. DOI:10.29001/2073-8552-2022-37-1-36-46.; Алексеева Я.В., Вышлов Е.В., Павлюкова Е.Н., Усов В.Ю., Марков В.А., Рябов В.В. Влияние разных фенотипов микрососудистого повреждения миокарда на сократительную функцию левого желудочка у пациентов с инфарктом миокарда с подъемом сегмента ST. Кардиология. 2021;61(5):23–31. DOI:10.18087/cardio.2021.5.n1500.; Фролов А.А., Починка И.Г., Шахов Б.Е., Шарабрин Е.Г., Кузьмичев К.В. Феномен коронарной микрососудистой обструкции (no-reflow) при проведении чрескожных коронарных вмешательств у пациентов с инфарктом миокарда. Патология кровообращения и кардиохирургия. 2020;24(1):18–27. DOI:10.21688/1681-3472-2020-1-18-27.; Capodanno D., Milluzzo R.P., Angiolillo D.J. Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use. Ther. Adv. Cardiovasc. Dis. 2019;13:1753944719893274. DOI:10.1177/1753944719893274.; Orzalkiewicz M., Hodson J., Kwok C.S., Ludman P.F., Giblett J.P., George S. et al. Comparison of routine versus selective glycoprotein IIb/IIIa inhibitors usage in primary percutaneous coronary intervention (from the British Cardiovascular Interventional Society). Am. J. Cardiol. 2019;124(3):373–80. DOI:10.1016/j.amjcard.2019.05.010.; Rigattieri S., Cristiano E., Giovannelli F., Tommasino A., Cava F., Citoni B. et al. Glycoprotein IIb/IIIa inhibitors may modulate the clinical benefit of radial access as compared to femoral access in primary percutaneous coronary intervention: a meta-regression and meta-analysis of randomized trials. J. Interv. Cardiol. 2021;9:9917407. DOI:10.1155/2021/9917407.; Rigattieri S., Lettieri C., Tiberti G., Romano M., Ferlini M., Testa L. Et al. Primary percutaneous coronary intervention with high-bolus dose tirofiban: The FASTER (favorite approach to safe and effective treat ment for early reperfusion). Multicenter Registry. J. Interv. Cardiol. 2022;5:9609970. DOI:10.1155/2022/9609970.; https://www.sibjcem.ru/jour/article/view/1796Test
الإتاحة: https://doi.org/10.29001/2073-8552-2023-38-2-122-131Test
https://doi.org/10.1093/eurheartj/ehy394Test
https://doi.org/10.15829/29/1560-4071-2020-4103Test
https://doi.org/10.3390/jcm11082233Test
https://doi.org/10.1152/ajpheart.00183.2018Test
https://doi.org/10.18087/cardio.2022.4.n2020Test
https://doi.org/10.1016/j.ahj.2005.07.012Test
https://doi.org/10.1001/jama.2012.421Test
https://doi.org/10.4244/EIJ-D-18-00885Test
https://doi.org/10.21688/1681-3472-2020-3S-68-76Test -
4دورية أكاديمية
المؤلفون: Jiawen Li, Yulong Li, Shuhong Su, Zhifang Wang, Haiwei Liu, Weixian Yang, Shubin Qiao, Yuejin Yang, Bo Xu, Runlin Gao, Jinqing Yuan, Xueyan Zhao
المصدر: Reviews in Cardiovascular Medicine, Vol 24, Iss 8, p 218 (2023)
مصطلحات موضوعية: bivalirudin, elective percutaneous coronary intervention, glycoprotein iib/iiia inhibitors, unfractionated heparin, Diseases of the circulatory (Cardiovascular) system, RC666-701
العلاقة: https://www.imrpress.com/journal/RCM/24/8/10.31083/j.rcm2408218Test; https://doaj.org/toc/1530-6550Test; https://doaj.org/article/4eb190aaea5b4895a3d0ea41844fd1f2Test
الإتاحة: https://doi.org/10.31083/j.rcm2408218Test
https://doaj.org/article/4eb190aaea5b4895a3d0ea41844fd1f2Test -
5دورية أكاديمية
المؤلفون: Wael Sumaya, William A.E. Parker, Heather M. Judge, Ian R. Hall, Rachel C. Orme, Zulfiquar Adam, James D. Richardson, Alexander M.K. Rothman, Kenneth P. Morgan, Julian P. Gunn, Robert F. Storey
المصدر: Platelets, Vol 32, Iss 4, Pp 555-559 (2021)
مصطلحات موضوعية: enoxaparin, glycoprotein iib/iiia inhibitors, p2y12 inhibitor, primary percutaneous coronary intervention, st-elevation myocardial infarction, unfractionated heparin, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Carolina Saleiro, Rogério Teixeira, Diana De Campos, João Lopes, Bárbara Oliveiros, Marco Costa, Lino Gonçalves
المصدر: Journal of Intensive Care, Vol 8, Iss 1, Pp 1-12 (2020)
مصطلحات موضوعية: Glycoprotein IIb/IIIa inhibitors, Abciximab, Eptifibatid, Cardiogenic shock, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s40560-020-00502-yTest; https://doaj.org/toc/2052-0492Test
-
7دورية أكاديمية
المؤلفون: Tavenier, Anne H., Claassens, Daniel M.F., Hermanides, Renicus S., Vos, Gerrit J.A., Bergmeijer, Thomas O., Kelder, Johannes C., Deneer, Vera H.M., van 't Hof, Arnoud W.J., ten Berg, Jurriën M.
المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, PECP – Centre for Clinical Therapeutics
مصطلحات موضوعية: clopidogrel, glycoprotein IIb/IIIa inhibitors, primary percutaneous coronary intervention, STEMI, ticagrelor, Radiology Nuclear Medicine and imaging, Cardiology and Cardiovascular Medicine
وصف الملف: application/pdf
-
8دورية أكاديمية
المؤلفون: Rasha Kaddoura, Mohamed Izham Mohamed Ibrahim, Daoud Al-Badriyeh, Amr Omar, Fahad Al-Kindi, Abdul Rahman Arabi
مصطلحات موضوعية: Biomedical and clinical sciences, Cardiovascular medicine and haematology, Pharmacology and pharmaceutical sciences, ST-segment elevation myocardial infarction (STEMI), Acute myocardial infarction, Thrombosis, Coronary vessel occlusion, Percutaneous coronary intervention (PCI), Thrombolysis, Left ventricular remodeling, Congestive heart failure, Mortality risk, Intracoronary thrombus burden, Aspiration thrombectomy (AT), Myocardial blush grade (MBG), ST-segment resolution (STR), Microvascular obstruction (MVO), Major adverse cardiovascular events (MACE), Glycoprotein IIb/IIIa inhibitors (GPI), Fibrinolytic agents, Thrombus dissolution
الإتاحة: https://doi.org/10.1371/journal.pone.0263270Test
https://figshare.com/articles/journal_contribution/Intracoronary_pharmacological_therapy_versus_aspiration_thrombectomy_in_STEMI_IPAT-STEMI_A_systematic_review_and_meta-analysis_of_randomized_trials/25257229Test -
9دورية أكاديمية
المؤلفون: Dong Huang, Juying Qian, Zongjun Liu, Yawei Xu, Xianxian Zhao, Zengyong Qiao, Weiyi Fang, Li Jiang, Wei Hu, Chengxing Shen, Chun Liang, Qi Zhang, Junbo Ge
المصدر: Frontiers in Cardiovascular Medicine, Vol 8 (2021)
مصطلحات موضوعية: thrombolysis/thrombolytic agents, acute myocardial infarction, percutaneous coronary intervention, glycoprotein IIB/IIIA inhibitors tirofiban, myocardial reperfusion, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fcvm.2021.710994/fullTest; https://doaj.org/toc/2297-055XTest
-
10دورية أكاديمية
المؤلفون: J.-P. Collet, H. Thiele, E. Barbato, O. Barthélémy, J. Bauersachs, D. L. Bhatt, P. Dendale, M. Dorobantu, T. Edvardsen, T. Folliguet, Ch. P. Gale, M. Gilard, A. Jobs, P. Jüni, E. Lambrinou, B. S. Lewis, Ju. Mehilli, E. Meliga, B. Merkely, O. Mueller, M. Roffi, F. H. Rutten, D. Sibbing, G. C.M. Siontis
المصدر: Российский кардиологический журнал, Vol 26, Iss 3 (2021)
مصطلحات موضوعية: guidelines, acute cardiac care, acute coronary syndrome, angioplasty, anticoagulation, antiplatelet, apixaban, aspirin, atherothrombosis, betablockers, bleedings, bivalirudin, bypass surgery, cangrelor, chest pain unit, clopidogrel, dabigatran, diabetes, dual antithrombotic therapy, early invasive strategy, edoxaban, enoxaparin, european society of cardiology, fondaparinux, glycoprotein iib/iiia inhibitors, heparin, high-sensitivity troponin, minoca, myocardial ischaemia, myocardial infarction, nitrates, non-st-elevation myocardial infarction, platelet inhibition, prasugrel, recommendations, revascularization, rhythm monitoring, rivaroxaban, stent, ticagrelor, triple therapy, unstable angina, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: https://russjcardiol.elpub.ru/jour/article/view/4418Test; https://doaj.org/toc/1560-4071Test; https://doaj.org/toc/2618-7620Test